{
  "docId": "019de072-7463-7169-8f31-7c4d89e9eac4",
  "docSlug": "d88eea3c6872c4e67cae911eb0680043",
  "documentTitle": "argenx SE | Results Presentation Deck | 10 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 1,
  "pageCount": 10,
  "prevPage": null,
  "nextPage": 2,
  "slideType": "cover",
  "function": "front_matter",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Includes author list and institutional affiliations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": "https://imgproxy.kitesheet.com/X0YPIgpur0XlncvsWdnPZQdRapYCkcFFKv4PiCJsBE0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kODhlZWEzYzY4NzJjNGU2N2NhZTkxMWViMDY4MDA0My9wMDAxLmpwZw",
  "slideHref": "/slides/019de072-7463-7169-8f31-7c4d89e9eac4/1",
  "deckHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4",
  "deckJsonHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4.json",
  "deckAnchorHref": "/decks/019de072-7463-7169-8f31-7c4d89e9eac4#slide-1",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.95,
        "x": 0.03,
        "y": 0.8
      },
      "kind": "disclaimer",
      "text": "1Department of Neurology, The University of North Carolina, Chapel Hill, NC, USA; 2Krembil Neuroscience Centre, University Health Network, Toronto, ON, Canada; 3Department of Neurology, University of South Florida, Morsani College of Medicine, Tampa, FL, USA; 4Penn Neuroscience Center, University of Pennsylvania, Philadelphia, PA, USA; 5Neurology Clinic, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia; 6Ghent University Hospital, Ghent, Belgium; 7Department of Neurology, School of Medicine, International University of Health and Welfare, Tokyo, Japan; 8Charité – Universitätsmedizin Berlin, Berlin, Germany; 9Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 10University of Kansas Medical Center, Kansas City, Kansas, USA; 11argenx, Ghent, Belgium; 12Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan; 13Department of Neurology, Leiden University Medical Center, Netherlands; 14Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59fc0ad1-4555-45e8-aa89-dc668f867615",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "image",
      "text": "adapt+ myasthenia gravis study",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a980890-5f35-4d25-9ac8-dbe44c4387ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.03,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "James F. Howard, Jr,1 Vera Bril,2 Tuan Vu,3 Chafic Karam,4 Stojan Peric,5 Jan L. De Bleecker,6 Hiroyuki Murai,7 Andreas Meisel,8 Said Beydoun,9 Mamatha Pasnoor,10 Antonio Guglietta,11 Peter Ulrichts,11 Caroline T’joen,11 Kimiaki Utsugisawa,12 Jan Verschuuren,13 Renato Mantegazza14 for the ADAPT Investigator Study Group",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d08cb2b7-e169-4550-8944-226882e4163d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.03,
        "y": 0.3
      },
      "kind": "title",
      "text": "Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "995ac3fe-e14d-4140-9898-f586aee465a9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Slide recipe: Cover",
      "slug": "cover-slide",
      "agent": "designer",
      "layer": "slide",
      "matchId": "19e0f0b8-855a-4ceb-8e5a-2c1355b73532",
      "evidence": "This is a cover slide with a title, logo, and other identifying information.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 1,
      "from": 1,
      "beatId": "440e44b6-899f-499d-8564-4a0be73acfe3",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The presentation starts by highlighting the limitations of current treatments for generalized myasthenia gravis.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": "https://imgproxy.kitesheet.com/fpk3XeVvAXjYIfyBxO1rPtdb2iz08zBmBzMHjjy0A8I/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kODhlZWEzYzY4NzJjNGU2N2NhZTkxMWViMDY4MDA0My9wMDAxLnBuZw",
  "thumbSrc": "https://imgproxy.kitesheet.com/NXUX7V-2uLKSwx-7YbiO3Pi167vJsErqZ3tIsMaBszA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kODhlZWEzYzY4NzJjNGU2N2NhZTkxMWViMDY4MDA0My9wMDAxLmpwZw",
  "thumbSrcAlt": "https://imgproxy.kitesheet.com/QE-0hnv8RIcRmnZx3ddFyRm5Wg9PGE1O5oXLU93V2D8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kODhlZWEzYzY4NzJjNGU2N2NhZTkxMWViMDY4MDA0My9wMDAxLnBuZw"
}